In particular, GPR37 agonists could be utilized to treat pain under different clinical settings, such as postoperative pain after surgery, inflammatory pain after infections and arthritis, and neuropathic pain after nerve injury, diabetes, and traumatic brain injury. This evidence concerns the gene GPR37 and arthritic joint disease.